Page 7,070«..1020..7,0697,0707,0717,072..7,0807,090..»

RBCC Initiates Talks With Emerging Drug Therapy Co.

Posted: Published on February 29th, 2012

MIRAMAR BEACH, Fla.--(BUSINESS WIRE)-- Rainbow BioSciences, the biotech division of Rainbow Coral Corp. (OTCBB: RBCC.OB - News) announced today that it has initiated talks with a drug development company pursuing a promising new therapy for Parkinsons disease. The market for Parkinson's disease drugs could reach a value of $3.75 billion by 2015, according to a 2011 report by business info provider Visiongain. New drugs and other products could significantly boost the Parkinson's treatment market and help advance the timeline for a cure for this debilitating disease. RBCC is always searching for new partnerships, joint ventures, and possible acquisitions that could increase the companys revenues and exposure in the biotech industry. The company is working on agreements with rising stars in need of assistance in funding, marketing and distributing their projectsRBCCs specialty. The company is exploring a possible deal with the drug therapy company as well as others as it pursues promising new opportunities for rapid growth. For more information on Rainbow BioSciences, Rainbow Corals biotech division, please visit http://www.rainbowbiosciences.com/investors. Rainbow BioSciences will develop new medical and research technology innovations to compete alongside companies such as Celgene Corp. (NASDAQ:CELG), Cardinal Health, Inc. (NYSE: CAH - News), Abbott Laboratories (NYSE:ABT) and Affymax, … Continue reading →

Posted in Parkinson's Treatment | Comments Off on RBCC Initiates Talks With Emerging Drug Therapy Co.

Charity golfers to the fore

Posted: Published on February 29th, 2012

Charity golfers to the fore 7:10pm Tuesday 28th February 2012 in News SCORES of golfers helped raise thousands of pounds for a cancer charity. For the past 11 years, Danny and Theresa Dyer have hosted a charity golf day to raise cash for causes that have supported their daughter Victoria who has cerebral palsy. So far the family has raised 36,200 for charities including East Oxford hospice Helen & Douglas House, respite nursing charity Rosy, the John Radcliffe Hospitals special care baby unit, and Bicester special needs school Bardwell. The family said 3,200 raised at the golf day last September, will go to Macmillan Cancer Support in the name of family friend Tad Williams. Mr Williams, who is undergoing treatment for cancer, has turned out for every golf day the family has organised, donating a major raffle prize each year. So this year he was given the honour of choosing the charity that would benefit. Mrs Dyer, 48, of Somerville Drive, Bicester, said: Tad was diagnosed with cancer two years ago and has been having treatment. He has had support from Macmillan and because we knew he was unwell we asked him to nominate the charity. Follow this link: Charity … Continue reading →

Posted in Cerebral Palsy Treatment | Comments Off on Charity golfers to the fore

CBR's Newborn Possibilities Program Provides Cord Blood Banking at No Cost to Families with an Identified Medical Need

Posted: Published on February 29th, 2012

SAN BRUNO,Calif., Feb. 29, 2012 /PRNewswire/ -- CBR (Cord Blood Registry) is working to expand awareness about its Newborn Possibilities Program to expectant parents nationwide. This corporate initiative is designed to ensure that a newborn's stem cells are processed and stored at no cost in cases of identified medical need and high-risk deliveries to enhance treatment options and increase access to clinical trials for conditions where limited therapies currently exist. Nearly 3,000 physicians have collected units for the Newborn Possibilities Program and CBR has stored more than 4,400 units under the program since its inception. (Logo: http://photos.prnewswire.com/prnh/20120216/AQ54476LOGO) "The Newborn Possibilities Program is not only providing an important treatment option for family members diagnosed with specific cancers, blood diseases, or immune diseases, but may also help eligible children to enroll in clinical trials that are using a newborn's own stem cells as a treatment for conditions like brain injury or cerebral palsy which have no treatments available today," said Vice President, Scientific and Medical affairs at CBR, Heather Brown. Expectant families may qualify for CBR's Newborn Possibilities Program if a family member has been diagnosed with a certain type of cancer (such as leukemia), or a blood/immune disorder (such as sickle … Continue reading →

Posted in Cerebral Palsy Treatment | Comments Off on CBR's Newborn Possibilities Program Provides Cord Blood Banking at No Cost to Families with an Identified Medical Need

ITRMC-PMDT PHOTO PRESENTATION.wmv – Video

Posted: Published on February 29th, 2012

27-02-2012 23:17 This video is a campaign in the FIGHT against MULTI DRUG-RESISTANT TUBERCULOSIS. Contains different activities of the treatment center; like, physical assessment and exam by a physician, daily observed treatment (DOT), home DOT, group discussions, general assemblies, screening, enrollment, drug and health education and social preparation for patient decentralization. TOGETHER, WE ARE THE CURE! ITRMC MDR-TB Treatment Center is at your service. You can help us in this battle by referring MDR-TB suspects! Nobody can do everything; but, everyone can do something! STOP TB! STOP MDR-TB! Read the original post: ITRMC-PMDT PHOTO PRESENTATION.wmv - Video … Continue reading →

Posted in MS Treatment | Comments Off on ITRMC-PMDT PHOTO PRESENTATION.wmv – Video

peer Usman hospital – Spiritual treatment – Video

Posted: Published on February 29th, 2012

29-02-2012 05:51 Hospital peer usman blood clot blood clot in brain bood cancer cancer blood quran cure Breast Cancer Brain Healing Surah Rahman Cancer Gastric cancer Kidney cancer Liver cancer Lung cancer Prostate Cancer Mesothelioma Ovarian Cancer Multiple Sclerosis Symptoms Diagnosis Aids Disease Quran... More: peer Usman hospital - Spiritual treatment - Video … Continue reading →

Posted in MS Treatment | Comments Off on peer Usman hospital – Spiritual treatment – Video

Biogen Idec seeks OK for no-needle MS treatment – The Boston Globe

Posted: Published on February 29th, 2012

JON CHASE FOR THE BOSTON GLOBE Susan Cohn-Child said the pill would be a game changer, especially for patients who have difficulty injecting themselves. For 15 years, Susan Cohn-Child has injected herself with a multiple sclerosis drug at least once a week to keep the disease in check. But Cohn-Child and thousands of other MS patients may soon be able to replace their needles with a pill being developed by Biogen Idec Inc. Following promising clinical trial results that sent Biogen Idec shares soaring last spring, the Weston biotechnology company yesterday filed a new drug application with the Food and Drug Administration seeking approval to sell the oral treatment, now known as BG-12. Most existing treatments for the autoimmune disorder, which affects about 400,000 people in the United States, require regular injections or intravenous infusions. One other oral treatment exists, but there is hope that the new Biogen Idec drug will prove a more effective option. Cohn-Child, 47, a financial manager who volunteers with the National Multiple Sclerosis Society to raise awareness about the disease, said the pill would be a game changer, especially for patients who have difficulty injecting themselves. The Acton mother currently uses Avonex, also made by … Continue reading →

Posted in MS Treatment | Comments Off on Biogen Idec seeks OK for no-needle MS treatment – The Boston Globe

Harper Government supports research on rare diseases

Posted: Published on February 29th, 2012

OTTAWA, Feb. 29, 2012 /CNW/ - The Harper Government today announced new research aimed at improving the lives of people with rare diseases. The announcement was made by the Parliamentary Secretary to the Minister of Health, Dr. Colin Carrie, on behalf of the Honourable Leona Aglukkaq, Minister of Health. "Our Government is committed to improving the quality of life of Canadians," said Dr. Carrie. "Today's announcement is about helping patients and families affected by a rare disease and improving the lives of those living with these conditions." The overall objective of the research is to transform fundamental biological research into medical practice and treatments in the area of rare diseases. For example, one team is conducting research on Fabry disease, a rare condition that affects many organ systems and results in a reduced life expectancy. This team will conduct a clinical research trial involving gene therapy, with the ultimate goal of establishing an effective treatment for this disease. In total, nine collaborative research teams will be supported. They will investigate a range of issues related to rare diseases, including basic biological science, health services, and policies. "CIHR is pleased to support these new research teams," said Dr. Lasko, Scientific Director … Continue reading →

Comments Off on Harper Government supports research on rare diseases

Growth Hormone Deficiency (GHD) Therapeutics – Pipeline Assessment and Market Forecasts to 2018

Posted: Published on February 29th, 2012

NEW YORK, Feb. 29, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Growth Hormone Deficiency (GHD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018 http://www.reportlinker.com/p0661223/Growth-Hormone-Deficiency-GHD-Therapeutics---Pipeline-Assessment-and-Market-Forecasts-to-2018.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Therapy Growth Hormone Deficiency (GHD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Summary GlobalData, the industry analysis specialist, has released its new report, "Growth Hormone Deficiency (GHD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018". The report is an essential source of information and analysis on the global Growth Hormone Deficiency (GHD) Therapeutics market. The report identifies the key trends shaping and driving the global Growth Hormone Deficiency (GHD) Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Growth Hormone Deficiency (GHD) Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Scope The report provides information on the key drivers and challenges of the Growth Hormone Deficiency (GHD) Therapeutics market. Its scope includes … Continue reading →

Posted in Hormone Replacement Therapy | Comments Off on Growth Hormone Deficiency (GHD) Therapeutics – Pipeline Assessment and Market Forecasts to 2018

Experts discuss stem cell banking ethics, policies

Posted: Published on February 29th, 2012

Experts discuss stem cell banking ethics, policies By Noimot OlayiwolaStaff Reporter Umbilical cord blood banking and transplantation, issues of ethics and policy as well as regulations governing stem cell banking were some of the high points of discussion during a session on Stem Cell Banking at the Qatar International Conference on Stem Cells Science and Policy, underway at the Qatar National Convention Centre. Sharing the Saudi Arabia experience on umbilical cord blood transplantation during a presentation, King Faisal Specialist Hospital and Research Centres blood bank (transfusion & donor services) director and of the Stem Cell Cord Blood Bank at the department of pathology and laboratory medicine, Dr Hind al-Humaidan, noted that the transplantation of allogeneic (taken from different individuals of the same species) bone marrow has been successfully used in the treatment of high risk or recurrent hematologic malignancies, bone marrow failure syndromes, selected hereditary immunodeficiency states and metabolic disorders. Early in the history of bone marrow transplantation, it was clear that access to a suitable donor was a major obstacle severely limiting the use of this potentially curative treatment modality. Although using an HLA (human leukocyte antigen) sibling donor is the best choice for transplantation, not all patients could … Continue reading →

Posted in Stem Cell Research | Comments Off on Experts discuss stem cell banking ethics, policies

Complete Genomics Announces Formation of Genomic Medicine Advisory Board

Posted: Published on February 29th, 2012

MOUNTAIN VIEW, Calif., Feb. 29, 2012 (GLOBE NEWSWIRE) -- Complete Genomics Inc. (Nasdaq:GNOM - News), the whole human genome sequencing company, today announced the formation of its Genomic Medicine Advisory Board (GMAB). The GMAB will provide insight and guidance on the best ways for the company to provide sequencing services to healthcare organizations and physicians interested in implementing genomic medicine in their practice. Inaugural board members include distinguished physicians and scientists. Robert Nussbaum, MD, Holly Smith Professor of Medicine, chief of the Division of Medical Genetics in the Department of Medicine, and director of the Cancer Risk and Cardiovascular Genetics Programs at the University of California, San Francisco, will serve as GMAB chairman. "There are a number of major challenges to deploying whole genome sequencing in the clinic," said Dr. Nussbaum. "The Complete Genomics GMAB is a wonderful opportunity to assemble thought leaders in genomic medicine to begin to define the 'clinical genome' and how to make it most useful and accessible to clinicians, establish technical and ethical standards, and address some of the regulatory and reimbursement obstacles that exist in this rapidly-evolving field. Complete Genomics is committed to doing this right." Founding members of the Complete Genomics GMAB include … Continue reading →

Comments Off on Complete Genomics Announces Formation of Genomic Medicine Advisory Board

Page 7,070«..1020..7,0697,0707,0717,072..7,0807,090..»